Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents

NCT00645411 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

3604

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Cell culture-derived influenza subunit vaccine (cTIV)
BIOLOGICAL: Egg derived influenza subunit vaccine (eTIV)
BIOLOGICAL: Cell culture-derived influenza subunit vaccine (cTIV)
BIOLOGICAL: Egg derived influenza subunit vaccine (eTIV)

Sponsor

Novartis

Collaborators

[object Object]